Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
APS-H5229 | Human | Human APCS / SAP / PTX2 Protein, His Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Miridesap | GSK-2315698; GSK-2315698A; Ro-63-8695 | Phase Ⅱ | Roche, GlaxoSmithKline, Pentraxin Therapeutics | Systemic amyloidosis | Details |
Dezamizumab | GSK-2398852 | Phase Ⅱ | Pentraxin Therapeutics, GlaxoSmithKline | Systemic amyloidosis | Details |
Miridesap/Dezamizumab | GSK-2315698/GSK-2398852 | Phase Ⅱ | Pentraxin Therapeutics, GlaxoSmithKline | Systemic amyloidosis | Details |
GSK-3039294 | GSK-3039294 | Phase Ⅰ | GlaxoSmithKline | Amyloid light chain amyloidosis (AL amyloidosis) | Details |
This web search service is supported by Google Inc.